Effects of SGLT2 inhibitors on eGFR in type 2 diabetic patients—the role of antidiabetic and antihypertensive medications

Recent randomized trials demonstrating the beneficial effects of sodium-glucose cotransporter 2 inhibitors (SGLT2is) in type 2 diabetes suggest that early reductions in eGFR upon initiation of SGLT2i therapy are associated with improved renal outcomes. Multiple concomitant medications, including ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Kitamura, Koichi, Hayashi, Koichi, Ito, Shinsuke, Hoshina, Yuiko, Sakai, Masahiro, Yoshino, Kaede, Endo, Keita, Fujitani, Shigeki, Suzuki, Toshihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099726/
https://www.ncbi.nlm.nih.gov/pubmed/33311577
http://dx.doi.org/10.1038/s41440-020-00590-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099726/
https://www.ncbi.nlm.nih.gov/pubmed/33311577
http://dx.doi.org/10.1038/s41440-020-00590-1

Ejemplares similares